Psychosocial stress and depressive symptoms are associated with increased risk of negative perinatal outcomes including preterm delivery and gestational hypertension. Inflammation is a likely mechanism by which distress may promote these outcomes. It is well-established that stress and depressive symptoms are associated with elevated serum inflammatory markers in nonpregnant populations. However, the immune system exhibits significant changes during pregnancy. Thus, the extent to which these findings extend to pregnancy is largely unknown. The current study examined associations among perceived stress, depressive symptoms, and serum inflammatory markers in a sample of 60 pregnant women. Fifty seven percent were African-American, 82% had completed high school or less education, and 63% reported an annual family income below $15,000. Participants completed the Perceived Stress Scale (PSS) and the Center for Epidemiologic Studies Depression Scale (CES-D). Serum levels of interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) were determined using high sensitivity immunoassays. Regression analyses demonstrated that after controlling for pre-pregnancy Body Mass Index (BMI), higher scores on the CES-D were related to significantly higher levels of IL-6 (b = .23, p = .05) and marginally higher TNF-a (b = .24, p = .06). Perceived stress was not significantly related to serum levels of IL-6 or TNF-a. In sum, these results indicate that depressive symptoms are associated with higher levels of maternal serum inflammatory markers during pregnancy. These data are consistent with the contention that depressive symptoms may contribute to negative perinatal outcomes via inflammatory pathways.
a b s t r a c t
Psychosocial stress and depressive symptoms are associated with increased risk of negative perinatal outcomes including preterm delivery and gestational hypertension. Inflammation is a likely mechanism by which distress may promote these outcomes. It is well-established that stress and depressive symptoms are associated with elevated serum inflammatory markers in nonpregnant populations. However, the immune system exhibits significant changes during pregnancy. Thus, the extent to which these findings extend to pregnancy is largely unknown. The current study examined associations among perceived stress, depressive symptoms, and serum inflammatory markers in a sample of 60 pregnant women. Fifty seven percent were African-American, 82% had completed high school or less education, and 63% reported an annual family income below $15,000. Participants completed the Perceived Stress Scale (PSS) and the Center for Epidemiologic Studies Depression Scale (CES-D). Serum levels of interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) were determined using high sensitivity immunoassays. Regression analyses demonstrated that after controlling for pre-pregnancy Body Mass Index (BMI), higher scores on the CES-D were related to significantly higher levels of IL-6 (b = .23, p = .05) and marginally higher TNF-a (b = .24, p = .06). Perceived stress was not significantly related to serum levels of IL-6 or TNF-a. In sum, these results indicate that depressive symptoms are associated with higher levels of maternal serum inflammatory markers during pregnancy. These data are consistent with the contention that depressive symptoms may contribute to negative perinatal outcomes via inflammatory pathways.
Ó 2009 Elsevier Inc. All rights reserved.
Introduction
Preterm birth affects 12-13% of births in the U.S. and is a leading cause of infant mortality (Goldenberg et al., 2008) . Greater stress and depressive symptoms have been related to increased risk of spontaneous preterm birth and preeclampsia, a leading cause of medically indicated preterm birth (Hobel et al., 2008; Kurki et al., 2000) . Relationships of stress and depressive symptoms with negative perinatal outcomes remain after controlling for behavioral and demographic explanations, suggesting a role for more direct physiological pathways.
A likely mechanism linking psychological distress with negative perinatal outcomes is inflammation. Earlier literature described successful pregnancy as an antiinflammatory phenomenon; this was presumed to prevent rejection of the fetus by the maternal immune system (Wegmann et al., 1993) . Later literature indicates that inflammatory processes are critical during the peri-implantation period and that immune adaptations during ongoing pregnancy are more complex than initially described (Chaouat et al., 2004; Raghupathy, 2001) . However, consistent evidence indicates that excessive inflammation is incompatible with healthy pregnancy; elevations in maternal serum inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), and interleukin-1b (IL-1b), are causally associated with increased risk negative perinatal outcomes including gestational hypertension and risk of preterm delivery (Raghupathy and Kalinka, 2008) .
It is well-established that stress and depressive symptoms predict elevations in circulating inflammatory cytokines in 
